Application of causal inference methods in the analyses of randomised controlled trials: a systematic review
Open Access
- 10 January 2018
- journal article
- review article
- Published by Springer Nature in Trials
- Vol. 19 (1) , 23
Abstract
Applications of causal inference methods to randomised controlled trial (RCT) data have usually focused on adjusting for compliance with the randomised intervention rather than on using RCT data to address other, non-randomised questions. In this paper we review use of causal inference methods to assess the impact of aspects of patient management other than the randomised intervention in RCTs. We identified papers that used causal inference methodology in RCT data from Medline, Premedline, Embase, Cochrane Library, and Web of Science from 1986 to September 2014, using a forward citation search of five seminal papers, and a keyword search. We did not include studies where inverse probability weighting was used solely to balance baseline characteristics, adjust for loss to follow-up or adjust for non-compliance to randomised treatment. Studies where the exposure could not be assigned were also excluded. There were 25 papers identified. Nearly half the papers (11/25) estimated the causal effect of concomitant medication on outcome. The remainder were concerned with post-randomisation treatment regimens (sequential treatments, n =5 ), effects of treatment timing (n = 2) and treatment dosing or duration (n = 7). Examples were found in cardiovascular disease (n = 5), HIV (n = 7), cancer (n = 6), mental health (n = 4), paediatrics (n = 2) and transfusion medicine (n = 1). The most common method implemented was a marginal structural model with inverse probability of treatment weighting. Examples of studies which exploit RCT data to address non-randomised questions using causal inference methodology remain relatively limited, despite the growth in methodological development and increasing utilisation in observational studies. Further efforts may be needed to promote use of causal methods to address additional clinical questions within RCTs to maximise their value.Keywords
Funding Information
- Medical Research Council (MC_UU_12023/21, MC_UU_12023/22 , MC_UU_12023/26, MC_UU_12023/21, MC_UU_12023/22, MC_UU_12023/26)
This publication has 59 references indexed in Scilit:
- Evaluating the Effect of Early Versus Late ARV Regimen Change if Failure on an Initial Regimen: Results From the AIDS Clinical Trials Group Study A5095Journal of the American Statistical Association, 2012
- Evaluation of Viable Dynamic Treatment Regimes in a Sequentially Randomized Trial of Advanced Prostate CancerJournal of the American Statistical Association, 2012
- Marginal Structural Models for Case-Cohort Study Designs to Estimate the Association of Antiretroviral Therapy Initiation With Incident AIDS or DeathAmerican Journal of Epidemiology, 2012
- Phase II Randomized Comparison of Topotecan Plus Cyclophosphamide Versus Topotecan Alone in Children With Recurrent or Refractory Neuroblastoma: A Children's Oncology Group StudyJournal of Clinical Oncology, 2010
- Estimating Absolute Risks in the Presence of NonadherenceEpidemiology, 2010
- Daily co-trimoxazole prophylaxis in severely immunosuppressed HIV-infected adults in Africa started on combination antiretroviral therapy: an observational analysis of the DART cohortThe Lancet, 2010
- Analysing Direct Effects in Randomized Trials with Secondary Interventions: An Application to Human Immunodeficiency Virus Prevention TrialsJournal of the Royal Statistical Society Series A: Statistics in Society, 2009
- Constructing Inverse Probability Weights for Marginal Structural ModelsAmerican Journal of Epidemiology, 2008
- Evaluating dose response from flexible dose clinical trialsBMC Psychiatry, 2008
- Postnatal depression in Southern Brazil: prevalence and its demographic and socioeconomic determinantsBMC Psychiatry, 2008